CSE1L and familial pancreatic carcinoma: The database showed that higher CSE1L expression was associated with worse outcomes in pancreatic cancer patients (P = 0.0054) (Fig. 2A).We next analyzed the correlation between CSE1L expression levels and the clinicopathological parameters of pancreatic cancer patients by the UALCAN database.